Revolutionizing neurotherapeutics: blood-brain barrier-on-a-chip technologies for precise drug delivery

Author:

Kantawala Burhan12,Shariff Sanobar12,Ramadan Nagham13,Fawaz Violette14,Hassan Youmna15,Mugisha Nadine16,Yenkoyan Konstantin27,Nazir Abubakar18ORCID,Uwishema Olivier1

Affiliation:

1. Oli Health Magazine Organization, Research and Education

2. Neuroscience Laboratory, Cobrain Centre

3. Faculty of Medicine

4. Faculty of Pharmacy, Beirut Arab University, Beirut, Lebanon

5. Faculty of Medicine and Surgery, Ahfad University for Women, Omdurman, Sudan

6. Faculty of Global Surgery, University of Global Health Equity, Kigali, Rwanda

7. Department of Biochemistry, Yerevan State Medical University named after Mkhitar Heratsi, Yerevan, Armenia

8. Department of Medicine, King Edward Medical University, Lahore, Pakistan

Abstract

Introduction: The blood-brain barrier (BBB) is a critical neurovascular unit regulating substances' passage from the bloodstream to the brain. Its selective permeability poses significant challenges in drug delivery for neurological disorders. Conventional methods often fail due to the BBB's complex structure. Aim: The study aims to shed light on their pivotal role in revolutionizing neurotherapeutics and explores the transformative potential of BBB-on-a-Chip technologies in drug delivery research to comprehensively review BBB-on-a-chip technologies, focusing on their design, and substantiate advantages over traditional models. Methods: A detailed analysis of existing literature and experimental data pertaining to BBB-on-a-Chip technologies was conducted. Various models, their physiological relevance, and innovative design considerations were examined through databases like Scopus, EbscoHost, PubMed Central, and Medline. Case studies demonstrating enhanced drug transport through BBB-on-a-Chip models were also reviewed, highlighting their potential impact on neurological disorders. Results: BBB-on-a-Chip models offer a revolutionary approach, accurately replicating BBB properties. These microphysiological systems enable high-throughput screening, real-time monitoring of drug transport, and precise localization of drugs. Case studies demonstrate their efficacy in enhancing drug penetration, offering potential therapies for diseases like Parkinson's and Alzheimer's. Conclusion: BBB-on-a-Chip models represent a transformative milestone in drug delivery research. Their ability to replicate BBB complexities, offer real-time monitoring, and enhance drug transport holds immense promise for neurological disorders. Continuous research and development are imperative to unlock BBB-on-a-Chip models' full potential, ushering in a new era of targeted, efficient, and safer drug therapies for challenging neurological conditions.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference85 articles.

1. The impact of dietary macronutrient intake on cognitive function and the brain;Muth;Clin Nutr,2021

2. The blood–brain barrier: an overview;Ballabh;Neurobiol Dis,2004

3. Drug delivery systems: an updated review;Tiwari;Int J Pharm Investig,2012

4. Physiological and pathological factors affecting drug delivery to the brain by nanoparticles;Islam;Adv Sci (Weinh),2021

5. Drug delivery across the blood–brain barrier;Khawli;Mol Pharm,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3